NEI Research for Low Vision and Blindness Accessibility Tools (R61/R33 Clinical Trial Optional)

The summary for the NEI Research for Low Vision and Blindness Accessibility Tools (R61/R33 Clinical Trial Optional) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
NEI Research for Low Vision and Blindness Accessibility Tools (R61/R33 Clinical Trial Optional): The purpose of this Notice of Funding Opportunity (NOFO) is to stimulate translational efforts in developing and implementing accessibility devices or interventions that apply new technologies to address challenges faced by individuals living with visual impairment. Critical elements of applications include a clear set of milestones that support development and testing of the tool, device, or intervention proposed; multidisciplinary and collaborative teams that include individuals with lived experience; and a tractable dissemination plan. The overall goal of the program is to push the boundaries of innovation in technology development to address accessibility needs of individuals with visual impairment and create resources that will be made available to the community. This NOFO uses a milestone driven and phased mechanism of award. Initial technology development and feasibility activities (R61 phase) may transition to expanded research support (R33 phase) for validation, larger-scale feasibility, and effectiveness studies. All applications must address both R61 and R33 phases.
Federal Grant Title: NEI Research for Low Vision and Blindness Accessibility Tools (R61/R33 Clinical Trial Optional)
Federal Agency Name: National Institutes of Health (HHS-NIH11)
Grant Categories: Health
Type of Opportunity: Discretionary
Funding Opportunity Number: RFA-EY-24-003
Type of Funding: Grant
CFDA Numbers: 93.867
CFDA Descriptions: Information not provided
Current Application Deadline: August 13th, 2024
Original Application Deadline: August 13th, 2024
Posted Date: May 16th, 2024
Creation Date: May 16th, 2024
Archive Date: September 18th, 2024
Total Program Funding:
Maximum Federal Grant Award:
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching: No
Last Updated: May 17th, 2024
Applicants Eligible for this Grant
State governments - County governments - City or township governments - Special district governments - Independent school districts - Public and State controlled institutions of higher education - Native American tribal governments (Federally recognized) - Public housing authorities/Indian housing authorities - Native American tribal organizations (other than Federally recognized tribal governments) - Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education - Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education - Private institutions of higher education - For-profit organizations other than small businesses - Small businesses - Others (see text field entitled "Additional Information on Eligibility" for clarification.)
Additional Information on Eligibility
Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed.
Link to Full Grant Announcement
https://grants.nih.gov/grants/guide/rfa-files/RFA-EY-24-003.html
Grant Announcement Contact
NIH Grants Information
[email protected]
See Section VII. Agency Contacts within the full opportunity announcement for all other inquires.
Similar Government Grants
NEI Small Business Innovation Research (SBIR) Cooperative Agreement for Early-Stage Clinic...
NEI Translational Research Program for Therapeutics (R33 Clinical Trial Not Allowed)
NEI Translational Research Program for Therapeutics (R61/R33 Clinical Trial Not Allowed)
NEI Institutional Mentored Physician Scientist Award (K12 Clinical Trial Optional)
NEI Collaborative Clinical Vision Research Project: Coordinating Center Grant (UG1 Clinica...
Nei Career Transition Award (K22)
NEI Translational Research Program On Therapy For Visual Disorders
NEI Clinical Study Planning Grant Program (R34)
More Grants from the National Institutes of Health
Mechanistic Studies to Investigate the Interrelationship Between Sleep and/or Circadian Rh...
CCRP Initiative: NIH Countermeasures Against Chemical Threats (CounterACT) Basic Research ...
NINDS Renewal Awards of SBIR Phase II Grants (Phase IIB) for Clinical Trials and Clinical ...
Mechanistic Studies to Investigate the Interrelationship Between Sleep and/or Circadian Rh...
Limited Competition: NIMHD Initiative for Improving American Indian and Alaska Native Canc...

FederalGrants.com is not endorsed by, or affiliated with, any government agency. Copyright ©2007-2024 FederalGrants.com